Market Closed -
Bombay S.E.
11:00:53 13/05/2024 BST
|
5-day change
|
1st Jan Change
|
101
INR
|
-0.79%
|
|
-6.61%
|
-21.16%
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
1,513
|
1,228
|
474.3
|
852.4
|
1,329
|
1,049
|
Enterprise Value (EV)
1 |
1,508
|
1,200
|
524.2
|
928.1
|
1,249
|
1,175
|
P/E ratio
|
29.6
x
|
15.9
x
|
7.13
x
|
40.6
x
|
12.5
x
|
-48
x
|
Yield
|
0.63%
|
1.17%
|
3.03%
|
1.12%
|
1.44%
|
0.91%
|
Capitalization / Revenue
|
1.39
x
|
0.61
x
|
0.25
x
|
0.48
x
|
0.43
x
|
0.51
x
|
EV / Revenue
|
1.38
x
|
0.59
x
|
0.28
x
|
0.52
x
|
0.4
x
|
0.57
x
|
EV / EBITDA
|
35.5
x
|
10.5
x
|
3.89
x
|
10.8
x
|
6.82
x
|
35.5
x
|
EV / FCF
|
-12.9
x
|
-138
x
|
-12.3
x
|
-26.6
x
|
8.51
x
|
-6.85
x
|
FCF Yield
|
-7.74%
|
-0.73%
|
-8.16%
|
-3.76%
|
11.8%
|
-14.6%
|
Price to Book
|
5.28
x
|
3.5
x
|
1.23
x
|
2.09
x
|
2.63
x
|
2.27
x
|
Nbr of stocks (in thousands)
|
9,583
|
9,583
|
9,583
|
9,583
|
9,583
|
9,583
|
Reference price
2 |
157.9
|
128.1
|
49.50
|
88.95
|
138.7
|
109.5
|
Announcement Date
|
05/09/18
|
24/08/19
|
06/09/20
|
02/09/21
|
03/09/22
|
02/09/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
1,092
|
2,020
|
1,888
|
1,781
|
3,127
|
2,067
|
EBITDA
1 |
42.5
|
114.3
|
134.9
|
86.31
|
183.2
|
33.1
|
EBIT
1 |
32.7
|
97
|
114.1
|
70.08
|
161.7
|
-2.654
|
Operating Margin
|
2.99%
|
4.8%
|
6.04%
|
3.94%
|
5.17%
|
-0.13%
|
Earnings before Tax (EBT)
1 |
79.1
|
110.4
|
92.37
|
31.94
|
145.2
|
-27.98
|
Net income
1 |
49.8
|
77.17
|
66.46
|
21
|
106.6
|
-21.85
|
Net margin
|
4.56%
|
3.82%
|
3.52%
|
1.18%
|
3.41%
|
-1.06%
|
EPS
2 |
5.326
|
8.054
|
6.940
|
2.190
|
11.12
|
-2.281
|
Free Cash Flow
1 |
-116.8
|
-8.719
|
-42.78
|
-34.93
|
146.8
|
-171.5
|
FCF margin
|
-10.69%
|
-0.43%
|
-2.27%
|
-1.96%
|
4.7%
|
-8.3%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
80.14%
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
137.72%
|
-
|
Dividend per Share
2 |
1.000
|
1.500
|
1.500
|
1.000
|
2.000
|
1.000
|
Announcement Date
|
05/09/18
|
24/08/19
|
06/09/20
|
02/09/21
|
03/09/22
|
02/09/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
49.9
|
75.8
|
-
|
126
|
Net Cash position
1 |
5
|
27.9
|
-
|
-
|
80.1
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
0.3695
x
|
0.878
x
|
-
|
3.792
x
|
Free Cash Flow
1 |
-117
|
-8.72
|
-42.8
|
-34.9
|
147
|
-172
|
ROE (net income / shareholders' equity)
|
21.3%
|
24.2%
|
18%
|
5.28%
|
23.4%
|
-4.52%
|
ROA (Net income/ Total Assets)
|
3.16%
|
7.12%
|
6.19%
|
3.33%
|
6.74%
|
-0.11%
|
Assets
1 |
1,576
|
1,084
|
1,074
|
630.5
|
1,582
|
20,597
|
Book Value Per Share
2 |
29.90
|
36.60
|
40.30
|
42.60
|
52.70
|
48.30
|
Cash Flow per Share
2 |
1.920
|
3.740
|
5.960
|
4.030
|
4.250
|
1.220
|
Capex
1 |
31.7
|
40.2
|
31.3
|
41.9
|
78.1
|
68.3
|
Capex / Sales
|
2.9%
|
1.99%
|
1.66%
|
2.35%
|
2.5%
|
3.3%
|
Announcement Date
|
05/09/18
|
24/08/19
|
06/09/20
|
02/09/21
|
03/09/22
|
02/09/23
|
|
1st Jan change
|
Capi.
|
---|
| -21.16% | 11.68M | | +3.33% | 3.67B | | -19.60% | 2.14B | | -7.64% | 1.99B | | +3.66% | 1.94B | | +0.22% | 1.72B | | +5.69% | 1.21B | | -18.30% | 1.08B | | -0.17% | 1.01B | | -6.30% | 906M |
Pesticide
|